Your browser doesn't support javascript.
loading
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Gerstein, Hertzel C; Ramasundarahettige, Chinthanie; Avezum, Alvero; Basile, Jan; Conget, Ignacio; Cushman, William C; Dagenais, Gilles R; Franek, Edward; Lakshmanan, Mark; Lanas, Fernando; Leiter, Lawrence A; Pogosova, Nana; Probstfield, Jeffrey; Raubenheimer, Peter J; Riddle, Matthew; Shaw, Jonathan; Sheu, Wayne H-H; Temelkova-Kurktschiev, Theodora; Turfanda, Ibrahim; Xavier, Denis.
Afiliação
  • Gerstein HC; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada. gerstein@mcmaster.ca.
  • Ramasundarahettige C; Department of Medicine, McMaster University, HSC 3V38, 1280 Main Street West, Hamilton, ON, L8S 4K1, Canada. gerstein@mcmaster.ca.
  • Avezum A; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada.
  • Basile J; International Research Center, Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil.
  • Conget I; Medical University of South Carolina, Charleston, SC, USA.
  • Cushman WC; Endocrinology and Nutrition Department, University of Barcelona, Barcelona, Spain.
  • Dagenais GR; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Franek E; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec, Canada.
  • Lakshmanan M; Mossakowski Clinical Research Center, Polish Academy of Sciences, Warsaw, Poland.
  • Lanas F; Eli Lilly and Company, Indianapolis, IN, USA.
  • Leiter LA; Universidad de La Frontera, Temuca, Chile.
  • Pogosova N; St. Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Canada.
  • Probstfield J; National Medical Research Center of Cardiology, Moscow, Russia.
  • Raubenheimer PJ; University of Washington, Seattle, USA.
  • Riddle M; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Shaw J; Department of Medicine, Oregon Health & Science University Portland, Oregon, USA.
  • Sheu WH; Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Temelkova-Kurktschiev T; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Turfanda I; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Xavier D; School of Medicine, National Defense Medical Center, Taipei, Taiwan.
Cardiovasc Diabetol ; 21(1): 158, 2022 08 22.
Article em En | MEDLINE | ID: mdl-35996147
BACKGROUND: The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A composite that captures information from both may provide a simpler way of assessing risk. METHODS: 9115 of 9901 Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) participants with both an ACR and eGFR at baseline were included in this post hoc epidemiologic analysis. The hazard of higher baseline levels of 1/eGFR and natural log transformed ACR (calculated as ln [ACR × 100] to eliminate negative values) and their interaction for incident major adverse cardiovascular events (MACE), kidney outcomes, and deaths was estimated. The hazard of the geometric mean of these two baseline measures (the kidney disease index or KDI) was also assessed. RESULTS: A non-linear relationship was observed between 1/eGFR and all three outcomes, and between ln [ACR × 100] and the kidney outcome. There was also a negative interaction between these two risk factors with respect to MACE and death. Conversely, a linear relationship was noted between the KDI and all three outcomes. People in the highest KDI fifth experienced the highest incidence of MACE, death, and the kidney outcome (4.43, 4.56, and 5.55/100 person-years respectively). C statistics for the KDI were similar to those for eGFR and albuminuria. CONCLUSIONS: The KDI combines the baseline eGFR and ACR into a novel composite risk factor that has a simple linear relationship with incident serious outcomes in people with diabetes and additional CV risk factors. Trial Registration clinicaltrials.gov NCT01394952.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Cardiovasc Diabetol Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Reino Unido